Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Current Deferred Revenue (2022 - 2026)

Updated

Phibro Animal Health's Current Deferred Revenue was $10.57 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 15.8% from $9.13 million a year earlier.

Analysis

Phibro Animal Health (PAHC) Current Deferred Revenue (2022 - 2026) Analysis & Trends

From fiscal Q4 2022 onward, Phibro Animal Health has reported Current Deferred Revenue for 5 quarters.

  • Current Deferred Revenue has now increased for three consecutive fiscal years, with a four-year compound annual growth rate of 12.4% (FY2022 to FY2026).
  • In earlier fiscal years, Current Deferred Revenue was $9.13 million in FY2025 (+22.3%), $7.46 million in FY2024 (+23.2%), $6.05 million in FY2023 (-8.5%) and $6.62 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.57 Mn
Jun 30, 2025 9.13 Mn
Jun 30, 2024 7.46 Mn
Jun 30, 2023 6.05 Mn
Jun 30, 2022 6.62 Mn
API Access

Phibro Animal Health Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PAHC&period=max&api_key=YOUR_API_KEY